Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study"

Acta Diabetol. 2022 Jun;59(6):869-870. doi: 10.1007/s00592-022-01861-8. Epub 2022 Mar 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cohort Studies
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Metformin